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problem. The purpose of this study la to evaluate prospectively the accuracy 
of helteel computed tomegraphy ongiogmphy in (HCTA) in acute pulmonary 
embolism (PE). 
Methods: 119 patients (59 :t= 15 yearn) with clinically suspected acute 
pulmonary embolism (PE) wore enrolled in this study. All patients underwent 
both HCTA (5 ram.collimation, ?.5.minis table speed. 2.7-ram effective slice 
thickness, 120-150 mt of contmt;t materiel at 4 ml/e rote) end digital selective 
pulmonary angiogmphy (DSA) within 12 hour~ of each other. All examinations 
were analyzed In consensus by two observem who were unaware of the 
findings in the reference otudy (DSA), 
Results: HCTA wee tochnlcally succeseful in 115/t 19 (96%) eaaee. BSA 
shewed PE in 41 patlent~ (34%)', ~9 in central veaeels (95,1%) nnd P in sub- 
segmental vessels (4,0%), The HCTA findings (~errataled well with DSA with 
two f~loe.positlve and one false.negative results, The prospective sensitivity 
of HCTA wee 95%, the specificity wan 98%, the positive predictive value were 
97% and the negative prodl0tlvo ~alue wee 97%, Both one false.positive and 
ono false.negative results were in sub~egmental level, One tree.negative 
mault had acute aortic hematoma detected by HCTA, 
Conoluslen: HCTA can accurately depict PE, Detection of aubsegmental 
clots remains a limitation of HCTA. oven if thin.alice thickness as ~,7 mm 
was used, 
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~ Prevention of Pulmonary Embolism by Inferior Vena 
Cave Filter In Patlente With Proximal Deed Vein 
Thrombosis 
FI, Faivm, For PREf~IC Inv~,~tt~nt, Char ~ in f  Vincent, f]e..~n~on, France 
B~IC'~IN/- Vane Cave Fillers (VCF) am increasingly used for the procreation 
of pulmonary embollt;m (PE), However, the beneflt/risk ratio el VCF has novor 
been aeseseed, 
MethoaL~: PREPIC was a mutticentor randemlsod chmcat eal ~n presumed 
high rt~;k paliente with proximal Deep Vein Thembosis (DVT) allocated to VCF 
or without (control, C), In addition, all patlonts received Hopafins followed 
by oral anticoagulant ot el least 3 months in both groups. Lung scans: 
(~ pulmonary angtograms) were performed at Day I and Day 10. Now 
asymptomatic or symptomatic PE at Day 10 was the pnmaP/ endpomt 
Symptomatic PE, ~oc, urront DVT and Drouth wore blindly evaluated for two 
yearn, 
Results: 400 patients worn included (200 VCF. 200 C). The moan ago 
was 72 years, 49% of patients had an initial PE and 90% hod at least one 
presumed risk factor of PE, At Day 10, PE rate was significantly lower in VCF 
group (1,1% vs 4.8% =n C, p = 0.03). At 2 years, PE was not stgnilicantly 
dllforent between VCF end C (3.4% vs 6.3%, p = 0.16): mecurront DVT was 
morn frequent in VCF group (20.8% vs 11.6%, p = 0.02): death rate was high 
tn both groups (21.6% vs 20.1%, NS). 
Conclusion: PREPIC Teal demonstrates the immediate fficacy o1 filter 
for pmeventlon of PE. However, because of the obson/ed excess of recurrent 
DVT and the absence of benefit on mortality in patients receiving filter, the 
systematic use of this device cs not to be recommended in this population. 
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~ 7  Recombinant Hlrudln In the Treatment of Heperln 
Induced Thromboeytopenla (HIT) Type II 
U, Janssons, A. Gmeinachor ~, P, Hanmth Universi~, Hospita! of Aachen. 
Germany; ~ Insitute for Immunolooy ancl Transfusion Mechcine. 
Emst.Montz-Amdt.Uni~rsi~, Gmi~u'nld. Germany 
HIT type It is a lifo-thmeatoning side-effect of hepadn therapy which is associ- 
ated with severn arterial and venous thromboembolic complications (TEC). 
Although affected patients require sustained pamentoral nticoagulation the 
mere suspicion of HIT type II mandates immediate cessation of hoparin ther- 
apy. Recombinant hirudln [rH] (Rofludan ~ , Hoechst, Germany) has recently 
been approved for treatment of HIT in Germany. 
Methods: All patients at our institution with clinical criteria of HIT and labo- 
ratory confirmation of heparin-induced antibodies were included in the study. 
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Hoperln we8 discontinued end replaced by rH according to a multi-center- 
study-protocol. RH wet; monitored by aPTT with a target range of 1.5-3,0 
fold prolongation of oPTT values at baseline. 
Results: 29 patients (59+ yearn, 19 main) were studied from 12/94 to 1/97, 
19 patients (05%) had TEC, Pletelet nadir under hepann therapy wse 60 :t- 
39 GIgWL, Significant sustained recovery of ptatelet values woe observed 
rapidly after start of rH, APTT values were wilhln forger values. Duration of 
rH treatment was 13 ~= 9 daye. no new TEC o~errad, 3 Patients died. noa~ 
of the deaths wee misted 1o rH. 
Conclrt~ion: Treatment of patients ~qffefing from HIT typ~ II wlth dd le~ing 
to rapid and sustained increase o1 plalelet ~'ounta while providing eun¢'~ent 
antleoagulstien, rH is t~ aafa and elfe¢tive alternative ant~-oagu!ant d~;I in 
patients with HIT type II, 
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~ l s  It Safe to Withhold or  Reveme Waffer!n ThemlW In 
Patients With Proethet!¢ Heart Va lwe After n ~ jor  
81~? 
K Ananthasebramaniam, J. Beeltie, V Javam, S, Bartok, H.S- Rosman. 
Henry FnM He~lrt and ~scutar Institute. Deln~l, &f~ch~ln, USA, 
The ask of thmmboembehsm when Wadann therapy is withhold Or ~velSed 
following a molar bleed in pmsthefio vahm patients is unknown. We identified 
29 patients (pts) with prosthetic head valves hosl)ilel[~l for a major bleed 
between 1990-1997, The aveffige age was 61 years with 16 males and 13 
females, 24 pts had St Jude valves, 4 had btoprosthehc valves and 2 each 
with ball Cage and tilting disc valves. V~htos were located in the mdrat posmon 
in 12 pts, aortic; tn 12, both mitml and aortK: in 4 and mcuspid in one. The 
average interval from valve surge W to the index bleed was 7 yearn. 26 pts 
had a gastrointestinal orretroperitoneat bleed, 2 had intrac~mal hemonhage 
and 1 had a subdurat hematoma. Average International Noemaltzed robe was 
3,3. Vitamin K was given to 5 and plasma to 7 to reverse antcoagulatton. 
Surgical intervention was required in 9 pts to treat bleeding, 4 o! ~t~,~m 
died in hospital. An additional 4 patients were lost to to;lewup. Average 
duration off anticeagutation was 15 days. ranging from 1 to 90. No pabent 
hod a clinically recognized thmmboembohc event while off anttcoagutat,on 
and them were no throraboembolic events in patients whose ant~Kjulahon 
was revemed. 23 patients had their wadann therapy resumed at the hma o| 
discharge. At 6 month tollowup. 10 patients had sustained recurrent bleeds. 
all gestmintsstinal, and one additional patient died. 
Conclusions: 1. Thromboembolic r~sk is low in patients with prosthetic 
heart valves and a major bleed when their anticoagulat~n is wtthhek:l or 
meversed. 2. Recurrent bleeding within 6 months o! resumption o! ant¢oag- 
ulation is common, 3. Although further study is warranted it appears that 
the ask of recunent bleeding after resumption of wartann may ouhvetgh the 
ask el thmemboembolism if wartann =s withheld in some patients ea~. after 
mesolution el major bleeding. 
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~ Differences Between Cardiologists and Generalists 
In Isehemlc Heart Disease Expenditures for 
Medicare Managed Care 
R.L. McNamara, N.R. Powe, T. Shelter, W. WoUer, G. Anderson. Johns 
Hopkins Un,versity, Baltimore, Maryland, USA 
Background." CapiV, tion paid to a pnncipal provider is becoming a more 
common method el payment under managed came. How elderly patients with 
ischomic heart disease (IHD) differ in cost under cardiologist (C) or generalist 
(G) care is unknown. 
Methods: We examined 1992 Medicare expenditures of 250,514 patients 
with IHD (ICD-9 codes 410-414). We defined pnncipal provider as the spe- 
cialty with the most Part B outpatient claims: 62% wore in the G (general 
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internists and famdy~general practlsenors) group, 13% in the C group, and 
25% in ether specialties 
Results: Not suq~lsingly, the C (vs, G) group had higher mean expen- 
ditures ($7,658 v~, $6,407) and wore more hkely to have acute myocardial 
mtarctK~ oe unstab~ ang!n~ than less severe IHD (27% vs~ 22%). The mean 
eXl~'td~um ex~ for t l~ C over the G group, however, was sub=tonically 
greater for the ~o IHD syndromes ($3,114) than for the less severe throne 
IHD condibons ($10~, 
COt1~!~'IL " ~ ~ f  e]IP0ndt~ums O~ p~t~ent~, who chose cardiologiStS 
aS their pf1~pa! I~rO~t(~f~ were predominantly in IHD patients w)lh acute 
~ l  i~a~ and unstab~ angina, two gm~ most likely to have 
beber ~ ou~'omes flora ~ care, 
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~ 0 0  Spe¢laltstl Make a O ~  In the Ma~nt  
of Unexplained Sy~'op~? 
ME Vl0kaL A_ Shanma. D.D Namla, FA Eh~en, J.S. Steinberg St 
L u ~ e ~  Hosp~a~ Cente~ a~ ~ un~rsm/ ~ ot 
~ns and Surgeon~ New ~ N~, USA 
S ~  I~ a Common cause, of eme,~gen(~ loom visits and hosp{tallzal~ons 
The causes of s~ncQpe are vaned, sometimes senous, and often require 
e~denst,,,e oe pro~¢ahve ~k-up  Irene to treatment. G~en current lrends =n 
managed care, we evaluated the effect of speoahst input on the diagnes~s 
and beatment OI syncope. We con(tu¢te0 a chaff re~w of 76 con~=cut~e 
p~s (71 ~= 18 ym, 27 makes) admdtedo~er a 6 me= pened wrth synO0pe. 41 pts 
(Gpt), managed only by a p~qnary pt~/s~m, were compared to 35 pts (Gp2) 
who had Z 1 speoat~t (~an: t~.  e t e ~ ,  neurology) I ~ .  
ResuRs: GlPt ann C_~ were sm~l.~ar mage (74 _+ 16 v'~69 ± 9yrs), history 
el heart d~ease (66% tm 63%), ptmr syncope (24% vs 14% p = 0.09), and 
baseline sinus r ~  (80% vs 74%). There was no difference m the num- 
be[ el non~nvasNe tests (echocard~ogrep~'ty. Ho~ter. carotid Doppler, brain 
m~a~ng. EEG, ,~jnal ap,~raged ECG, cardmc sWess test) performed (2.3 ~- 
1 6 vs 2.4 ± 1.5). Ho~e~er. Gp2 pts were more likely to have specialized 
tests ( ~  Stu~, car~ac catheter ,  bit table) (0 ¢ 0 vs 
0.7 ± 0.8). Impe l ,  G~ pts were Iwce as likely to have a diagrmsls of 
the cause of syncope made (22% vs 49%, p = 0.026) and ~k~-ed therapy 
m~bated (15% vs 37%, p = 0.03). Despite more speoa~.,zed tests m Gp2. the 
rength of stay d~d not drfter i7 ~- 8vs7 ~ 5 days). 
~ :  Cases of syncope m ~ a speoahst was mvok'ed were 
more likely to have an ebotog~ diagnosis ma~*e and appropnate therapy 
m~ated. 
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~-~ Mortality Fol lowing Acute Myocardial  Infarction 
Accord ing  to  Physician Experience, Technical 
Training, and  Specialty 
J.G Jofli$. K.J. AnStrom, JA  Stafford. D.B. Mark. Du~e Chn,¢.3! .~*sea,'c,'~ 
I~e .  Durham. NC USA 
We prev~sty demonstrated a relationship between ao'm=ssmn by a carcliof 
ogist and lower mortality for 8.241 acute myocardial infarc~on pabent5 over 
age 65. TO understand the aslx.cts el speoalty care assooated wdh better 
outcomes, we examined 1 year morlality according to expenence (annual 
number o! acute myocardial infarction admissions per physioan) and tech- 
nical flaming (inve~rve card=oleg~st). After adjusting for patient and hospdal 
characteristics, there was a trend toward lower mortality for more expen- 
enced phy~ioans regardless el speoa~, and substanbally lower mortality 
for physicians hained in cardiac cathetenzation 
Hazard ratio and 95% confidence interval 
Admittin'q physician ~ l  
Cardiology vs. pnmary care ~ I 
Invasive cardiology vs. primary care 
High volume vs. low volume 0.9.0 J 
Medium volume vs. low volume 
I <1---.-- ~- I1~ I 
05 Better 1.0 Worse t 5 
While it is possible that unmeasured patient and hospital factors led to 
the better outcomes, this study suggests that physician factors involwng 
both technical training and experience are associated with improved acute 
myocardial infarction survival. 
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~ Impact of Phyaician Type on Hospltl! Charg~ for 
ORG 127 (Heart Failure and Shock): Heart Failure 
3i~¢iallsts Provide More Coat-ef!U¢livo Care 
D, Chomsky, J Butter, S, Dav~s, K 0able. J,R Wilson VanOed~/T 
Nast~vr/~, TN, USA 
Most patlent~ with f'~P~rt ta=tur0 am currently m ~  by g;/~ys~el,~ 
little specific Oxpedise in hear failure, Trensfemng the ~re O~ ~uCh p~t~l  
to heart failure sPeCialists m~ght i~rove ~ ~nd ( :k~ ~s ,  
To IOst thi~ hypothe~iS, we e~amme¢l t1141z in l~ O! phy~l¢l~rl ~ Oft 
hoepnat charges t~ DRG 127 (heart failur~ and 8ho~k), Froffl 4 /~ to ~]/97, 
764 patients were e~/rn~e0 to Vanderbilt ~ 1  Cemtef ~ heart fmture, 
of whom 2t l  were managed by 3 heart failure specialists (HFS). 159 by 
camlelogmts (C), and 394 by intemim and pnmary ,=.am phy~cmns (PCP). 
Patients managed by HFS had a h~gher aCurty, as e ~  by a ~ r  
motlality fate (HFS: (~=, C: 4%, PCP: 3%) an(] hlgl~r chaq~l~ foe out~ 
(:-$15,(]00 total charges) (HFS; ~9,1S3, C ~-~',643, PCP: ~?.3,767), The 
percentage of outhets was similar m all groups (HFS: 8%, C: t1%, PCP: 
9%) When outtmrs were excluded, to partially correct foe acuffy differences, 
both langth of stay (LOS) and total ~ t  ~:ha.ges were s,gn~ficantly lower 
m patmnta managed by heart tadure Specialists (' p ~ 001, " p .  0.001 vs 
HFS) 
N LOS Changes,Patient 
HFS I~ 32 • ~. s4a~ ~ ~s  
PCP 359 38~:21" $5848 ~: 2810" 
CarO~3k~g=sls 142 37 ~ 2 O" S6474 ± 3007 ~ 
These findings suggest that hear fatture spet3alists treat mpatients wffh 
heart fadure more cost..eftectiveh/than other physician groups. 
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• l 879-5 i Impact of Focal Heart Attack Disclosure Document 
at the Time of Discharge on the Appmpria~ 
Management of  Patients With Acute l l~rd ia l  
In lat~]on 
RH Mollie, E. Notan, S. Dos, G. Keady. D. Karavite, P. Russman, 
K Saran. KA  Eagle. J. Ntcklas. Dnns~on ot Cardeology; UmversRy of 
M~ch~an. Ann Arbor. MI. USA 
We developed a Heart Attack Discharge Summary (HADS) as a document 
to empower parents (PTS) to query pr~sloans (MD) about key elements 
of acute myocardial infarction (AMI) care The PTS and MD re~ewed and 
cosigned the HADS at the time of discharge, documentin~ quality of AMI care 
indicators mcfudlng use of discharge aspirin (ASA), ACE inhibitor's (ACE), 
beta-t.~-kers (BB), lipid lowenng agents (LPA), avo¢dance of calcium-block- 
ers (CB), copy of ECG (ECG) to the FTS, smoking cessation (SC), d~et 
counseling (DC) and outdoabent rehabilitalTon (OR). HADS use was variable 
among MD throughout the study. Thvs analysis examines the relationship of 
using HADS and adherence to key dmcharge goals. 
Method: We studied 611 consecuhve AMI PTS between 3/95 and 2/97 
HADS was completed in 275 FTS. PTS who died (n = 76) and w~h mvsszng 
follow-up (n = 4) were excluded. The mean age was 62 years (357 males 
and 178 tematas). 
ResultS: The table lists % of PTS where quality indicators were met 
N ASA BB ACE LPA 
No HAD.% 256 ~ 90 8 86 56 
HADS 275 99 97 6 95 72 
p value 0 022 0 002 0 01 0 00t 
CB ECG OR SC OC 
No HADS 92 2~ 63 87 96 
HADS 90 70 82 98 96 
p value 0 47 0 001 - 0 001 0 go! 0 63 
Conclusions- 1 HAOS use correlated with higher adherence to quality of 
care mclicators for AMI. 2. PTS empewerment and MD reminders vmpreve 
adherence to quality of care red,caters for AMI. 
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~9~ The of Procedural Skills in Importance Physician 
Management Decisions for Acute Myocardial 
Infarction 
J.G. Jollis. K.J. Anstrom. J.A. Stafford, D.B Mark. Duke Clmrcal Research 
Institute. Durham. NC. USA 
Previous work demonstrated, ira', acute myOCa.~-'= =1 infarction (AMI) pahents 
